vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and MOVADO GROUP INC (MOV). Click either name above to swap in a different company.
MOVADO GROUP INC is the larger business by last-quarter revenue ($186.1M vs $168.4M, roughly 1.1× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 1.9%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs 2.9%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Movado is a luxury American watch brand originally founded in 1881 in Switzerland. Movado means "movement" in Esperanto. The watches are known for their signature metallic dot at 12 o'clock and minimalist style; the company is best known for its Museum Watch.
ESPR vs MOV — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $186.1M |
| Net Profit | — | $9.6M |
| Gross Margin | — | 54.3% |
| Operating Margin | 50.6% | 6.3% |
| Net Margin | — | 5.1% |
| Revenue YoY | 143.7% | 1.9% |
| Net Profit YoY | — | 89.8% |
| EPS (diluted) | $0.32 | $0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $186.1M | ||
| Q3 25 | $87.3M | $161.8M | ||
| Q2 25 | $82.4M | $131.8M | ||
| Q1 25 | $65.0M | $181.5M | ||
| Q4 24 | $69.1M | $180.5M | ||
| Q3 24 | $51.6M | $157.0M | ||
| Q2 24 | $73.8M | $134.4M | ||
| Q1 24 | $137.7M | $175.8M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | $-31.3M | $3.0M | ||
| Q2 25 | $-12.7M | $1.4M | ||
| Q1 25 | $-40.5M | $8.1M | ||
| Q4 24 | — | $4.8M | ||
| Q3 24 | $-29.5M | $3.5M | ||
| Q2 24 | $-61.9M | $2.0M | ||
| Q1 24 | $61.0M | $9.8M |
| Q4 25 | — | 54.3% | ||
| Q3 25 | — | 54.1% | ||
| Q2 25 | — | 54.1% | ||
| Q1 25 | — | 54.2% | ||
| Q4 24 | — | 53.5% | ||
| Q3 24 | — | 54.3% | ||
| Q2 24 | — | 54.3% | ||
| Q1 24 | — | 53.5% |
| Q4 25 | 50.6% | 6.3% | ||
| Q3 25 | -11.4% | 2.5% | ||
| Q2 25 | 8.6% | 0.2% | ||
| Q1 25 | -34.0% | 5.1% | ||
| Q4 24 | -6.4% | 3.3% | ||
| Q3 24 | -31.0% | 1.7% | ||
| Q2 24 | 3.5% | 1.6% | ||
| Q1 24 | 52.5% | 6.1% |
| Q4 25 | — | 5.1% | ||
| Q3 25 | -35.9% | 1.8% | ||
| Q2 25 | -15.4% | 1.1% | ||
| Q1 25 | -62.2% | 4.4% | ||
| Q4 24 | — | 2.7% | ||
| Q3 24 | -57.2% | 2.2% | ||
| Q2 24 | -83.9% | 1.5% | ||
| Q1 24 | 44.3% | 5.6% |
| Q4 25 | $0.32 | $0.42 | ||
| Q3 25 | $-0.16 | $0.13 | ||
| Q2 25 | $-0.06 | $0.06 | ||
| Q1 25 | $-0.21 | $0.36 | ||
| Q4 24 | $-0.14 | $0.21 | ||
| Q3 24 | $-0.15 | $0.15 | ||
| Q2 24 | $-0.33 | $0.09 | ||
| Q1 24 | $0.34 | $0.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $183.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-302.0M | $497.5M |
| Total Assets | $465.9M | $751.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $183.9M | ||
| Q3 25 | $92.4M | $180.5M | ||
| Q2 25 | $86.1M | $203.1M | ||
| Q1 25 | $114.6M | $208.5M | ||
| Q4 24 | $144.8M | $181.5M | ||
| Q3 24 | $144.7M | $198.3M | ||
| Q2 24 | $189.3M | $225.4M | ||
| Q1 24 | $226.6M | $262.1M |
| Q4 25 | $-302.0M | $497.5M | ||
| Q3 25 | $-451.4M | $489.9M | ||
| Q2 25 | $-433.5M | $493.2M | ||
| Q1 25 | $-426.2M | $481.3M | ||
| Q4 24 | $-388.7M | $491.3M | ||
| Q3 24 | $-370.2M | $492.0M | ||
| Q2 24 | $-344.2M | $489.6M | ||
| Q1 24 | $-294.3M | $505.9M |
| Q4 25 | $465.9M | $751.9M | ||
| Q3 25 | $364.0M | $748.7M | ||
| Q2 25 | $347.1M | $747.2M | ||
| Q1 25 | $324.0M | $729.2M | ||
| Q4 24 | $343.8M | $747.2M | ||
| Q3 24 | $314.1M | $742.5M | ||
| Q2 24 | $352.3M | $736.0M | ||
| Q1 24 | $373.1M | $756.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $12.3M |
| Free Cash FlowOCF − Capex | — | $11.6M |
| FCF MarginFCF / Revenue | — | 6.2% |
| Capex IntensityCapex / Revenue | 0.0% | 0.4% |
| Cash ConversionOCF / Net Profit | — | 1.28× |
| TTM Free Cash FlowTrailing 4 quarters | — | $35.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $12.3M | ||
| Q3 25 | $-4.3M | $-3.8M | ||
| Q2 25 | $-31.4M | $-7.2M | ||
| Q1 25 | $-22.6M | $39.1M | ||
| Q4 24 | $-35.0M | $-4.7M | ||
| Q3 24 | $-35.3M | $-17.8M | ||
| Q2 24 | $-7.2M | $-18.1M | ||
| Q1 24 | $53.8M | $69.4M |
| Q4 25 | — | $11.6M | ||
| Q3 25 | — | $-5.1M | ||
| Q2 25 | — | $-8.7M | ||
| Q1 25 | — | $37.5M | ||
| Q4 24 | — | $-7.2M | ||
| Q3 24 | $-35.5M | $-20.1M | ||
| Q2 24 | $-7.3M | $-19.7M | ||
| Q1 24 | $53.8M | $67.8M |
| Q4 25 | — | 6.2% | ||
| Q3 25 | — | -3.1% | ||
| Q2 25 | — | -6.6% | ||
| Q1 25 | — | 20.7% | ||
| Q4 24 | — | -4.0% | ||
| Q3 24 | -68.7% | -12.8% | ||
| Q2 24 | -9.9% | -14.7% | ||
| Q1 24 | 39.0% | 38.6% |
| Q4 25 | 0.0% | 0.4% | ||
| Q3 25 | 0.0% | 0.8% | ||
| Q2 25 | 0.0% | 1.2% | ||
| Q1 25 | 0.0% | 0.9% | ||
| Q4 24 | 0.0% | 1.4% | ||
| Q3 24 | 0.3% | 1.5% | ||
| Q2 24 | 0.1% | 1.2% | ||
| Q1 24 | 0.1% | 0.9% |
| Q4 25 | — | 1.28× | ||
| Q3 25 | — | -1.27× | ||
| Q2 25 | — | -5.08× | ||
| Q1 25 | — | 4.86× | ||
| Q4 24 | — | -0.98× | ||
| Q3 24 | — | -5.14× | ||
| Q2 24 | — | -8.97× | ||
| Q1 24 | 0.88× | 7.06× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
MOV
| Other | $81.4M | 44% |
| Owned Brands Category | $46.0M | 25% |
| Sales Channel Directly To Consumer | $35.3M | 19% |
| Company Stores | $23.4M | 13% |
